RTW Investments Deal History & Licensing Activity
RTW Investments is a life sciences. Over the past three years, RTW Investments has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Oncology
RTW Investments Recent Deal Activity
Licensing, acquisition, and partnership transactions involving RTW Investments in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| aglatimagene besadenovec (CAN-2409) | Candel Therapeutics | Other | Phase 3 | license | Feb 2026 |
RTW Investments Pipeline Focus
Therapeutic areas and modalities where RTW Investments is most active based on deal history and clinical trial data.
RTW Investments Strategic Signals
Key indicators of RTW Investments's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches RTW Investments's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About RTW Investments Licensing & Deal Activity
RTW Investments is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, RTW Investments ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for RTW Investments include Oncology (2 deals and trials). In terms of modality, RTW Investments has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for RTW Investments and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against RTW Investments's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.